TotalMarketCap

Genprex

GNPXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.697 M

$2.07 -3.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Genprex (GNPX) has a market capitalization of $1.70M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$16.2M

Loss-making

Shares outstanding

819,709

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #485EnlivexENLV$1.95M
  2. #486Propanc BiopharmaPPCB$1.72M
  3. #487GenprexGNPX$1.70M
  4. #488XORTX TherapeuticsXRTX$1.65M
  5. #489OragenicsOGEN$1.55M

What if Genprex were worth as much as…

Open the what-if tool →

Gold $28.2T

$34,447,429

Per share 16,641,270× higher

Bitcoin $1.53T

$1,863,890

Per share 900,430× higher

Apple $5.02T

$6,118,978

Per share 2,956,028× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Genprex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.